Clinical Trial Update: AZD1152 in Patients With Advanced Solid Malignancies [Phase 1]

View source ↗

Summary

AstraZeneca reports a Phase 1 clinical trial update for AZD1152 in patients with advanced solid malignancies. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AZD1152 (barasertib)

Snippet

Sponsor: AstraZeneca | Conditions: Tumors | Phase 1 | Status: COMPLETED